News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,487 Results
Type
Article (41711)
Company Profile (254)
Press Release (666522)
Section
Business (208376)
Career Advice (2099)
Deals (35907)
Drug Delivery (98)
Drug Development (82104)
Employer Resources (173)
FDA (16329)
Job Trends (15060)
News (351388)
Policy (33072)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2627)
Accelerated approval (2)
Adcomms (25)
Allergies (77)
Alliances (50309)
ALS (76)
Alzheimer's disease (1339)
Antibody-drug conjugate (ADC) (102)
Approvals (16311)
Artificial intelligence (213)
Autoimmune disease (11)
Automation (14)
Bankruptcy (359)
Best Places to Work (11779)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (179)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (234)
Cancer (1812)
Cardiovascular disease (134)
Career advice (1752)
Career pathing (30)
CAR-T (131)
Cell therapy (382)
Cervical cancer (13)
Clinical research (66225)
Collaboration (705)
Compensation (393)
Complete response letters (18)
COVID-19 (2600)
CRISPR (32)
C-suite (185)
Cystic fibrosis (97)
Data (1722)
Decentralized trials (2)
Denatured (17)
Depression (36)
Diabetes (229)
Diagnostics (6429)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (106)
Drug pricing (98)
Drug shortages (24)
Duchenne muscular dystrophy (65)
Earnings (87493)
Editorial (27)
Employer branding (21)
Employer resources (148)
Events (113870)
Executive appointments (599)
FDA (17302)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (637)
Gene editing (86)
Generative AI (19)
Gene therapy (261)
GLP-1 (669)
Government (4458)
Grass and pollen (4)
Guidances (46)
Healthcare (19099)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (92)
Indications (23)
Infectious disease (2721)
Inflammatory bowel disease (127)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (323)
IPO (16674)
IRA (40)
Job creations (3719)
Job search strategy (1497)
Kidney cancer (9)
Labor market (26)
Layoffs (451)
Leadership (15)
Legal (8023)
Liver cancer (69)
Lung cancer (269)
Lymphoma (119)
Machine learning (2)
Management (59)
Manufacturing (250)
MASH (57)
Medical device (13531)
Medtech (13536)
Mergers & acquisitions (19641)
Metabolic disorders (589)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (71)
Neuropsychiatric disorders (23)
Neuroscience (1771)
NextGen: Class of 2025 (6621)
Non-profit (4585)
Northern California (2221)
Now hiring (35)
Obesity (324)
Opinion (203)
Ovarian cancer (61)
Pain (70)
Pancreatic cancer (71)
Parkinson's disease (118)
Partnered (17)
Patents (180)
Patient recruitment (81)
Peanut (45)
People (58205)
Pharmaceutical (66)
Pharmacy benefit managers (18)
Phase I (20609)
Phase II (29149)
Phase III (21712)
Pipeline (810)
Podcasts (44)
Policy (101)
Postmarket research (2649)
Preclinical (8749)
Press Release (64)
Prostate cancer (84)
Psychedelics (32)
Radiopharmaceuticals (243)
Rare diseases (342)
Real estate (6045)
Recruiting (65)
Regulatory (22390)
Reports (43)
Research institute (2380)
Resumes & cover letters (358)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (60)
Series A (115)
Series B (68)
Service/supplier (11)
Sickle cell disease (50)
Southern California (1897)
Special edition (13)
Sponsored (29)
Startups (3628)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (26)
United States (19581)
Vaccines (632)
Venture capitalists (34)
Webinars (12)
Weight loss (222)
Women's health (32)
Worklife (14)
Date
Today (167)
Last 7 days (754)
Last 30 days (2955)
Last 365 days (34640)
2025 (5734)
2024 (35533)
2023 (40487)
2022 (51674)
2021 (56305)
2020 (54774)
2019 (47467)
2018 (35746)
2017 (32843)
2016 (32309)
2015 (38453)
2014 (32129)
2013 (27108)
2012 (29402)
2011 (30038)
2010 (28129)
Location
Africa (763)
Alabama (48)
Alaska (7)
Arizona (216)
Arkansas (12)
Asia (39129)
Australia (6449)
California (5061)
Canada (1764)
China (420)
Colorado (230)
Connecticut (240)
Delaware (112)
Europe (85005)
Florida (743)
Georgia (172)
Idaho (57)
Illinois (470)
India (20)
Indiana (276)
Iowa (7)
Japan (128)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (67)
Maryland (782)
Massachusetts (3858)
Michigan (206)
Minnesota (351)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1436)
New Mexico (27)
New York (1447)
North Carolina (904)
North Dakota (7)
Northern California (2221)
Ohio (179)
Oklahoma (13)
Oregon (32)
Pennsylvania (1146)
Puerto Rico (6)
Rhode Island (23)
South America (1141)
South Carolina (13)
South Dakota (1)
Southern California (1897)
Tennessee (83)
Texas (742)
Utah (157)
Virginia (116)
Washington D.C. (57)
Washington State (479)
West Virginia (3)
Wisconsin (48)
708,487 Results for "meditech international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MEDITECH Shares Strategies for Interconnected Care and Meaningful Data Exchange at ViVE 2025
January 22, 2025
·
4 min read
MEDITECH to Spotlight Intelligent Interoperability at HIMSS24
MEDITECH is once again excited to feature its latest interoperability innovations in the HIMSS Interoperability Showcase.
March 7, 2024
·
5 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Pharm Country
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
STRATA Skin Sciences, Inc. announced the expansion of a direct distribution agreement with Kosmo Meditech, which is now assigned to Kosmo’s corporate parent, Cutech, Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea.
December 29, 2023
·
4 min read
Press Releases
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
March 4, 2025
·
4 min read
Press Releases
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
·
6 min read
Press Releases
WW International, Inc. Announces CFO Transition
November 27, 2024
·
4 min read
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
1 of 70,849
Next
